Connect with us

Health

Parliament draws the battle lines on Europe’s Critical Medicines Act

SHARE:

Published

4 weeks ago

on

We use your sign-up to provide content in ways you've consented to and to improve our understanding of you. You can unsubscribe at any time.

The European Parliament gave a resounding endorsement of Tomislav Sokol’s (EPP, Croatia) report on the Critical Medicines Act (CMA), setting out the Parliament’s battle lines for negotiations.

With 503 votes in favour, 57 against and 108 abstentions, the report sailed through Parliament, but is likely to face more choppy waters when it comes into contact with the Council’s position in trilogues.

Normally, the opprobrium of the Parliament’s EPP group would be aimed at China’s anti-competitive behaviour, but in 2026, the aggressive actions of the US, accusing Europe of “free-loading” with its lower prices and US efforts to repatriate medicines production - or else - have helped rally MEPs. “(Trump) has put pressure on individual pharma companies to conclude tens of billions worth of investments in the US”, said Sokol...

Share this article:

Share this:
Related Topics:
EU Reporter publishes articles from a variety of outside sources which express a wide range of viewpoints. The positions taken in these articles are not necessarily those of EU Reporter. Please see EU Reporter’s full Terms and Conditions of publication for more information EU Reporter embraces artificial intelligence as a tool to enhance journalistic quality, efficiency, and accessibility, while maintaining strict human editorial oversight, ethical standards, and transparency in all AI-assisted content. Please see EU Reporter’s full A.I. Policy for more information.
Advertisement

Trending